Since SNHG7 silencing significantly downregulated the PI3K, p-AKT, and p-mTOR in cisplatin-resistant NSCLC cells, SNHG7 promoted cisplatin-resistance via MRD1 and BCRP upregulations through PI3K/AKT pathway in NSCLC [88]. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.